Company profile
Alrise Biosystems company profile
ALRISE develops controlled release depot formulations for protein, peptide and small molecule drugs. The cornerstone of ALRISE’s business is its patented drug delivery technology for the encapsulation of hydrophilic or hydrophobic drug substances in biodegradable polymeric nano or micro particles. ALRISE not only offers a unique technology, but also provides a platform from which products can be developed to meet the ever increasing needs of pharma, biotech, and generics companies. ALRISE’s mission is to make its innovative encapsulation technology available to a broader user spectrum and ultimately to create benefit for patients worldwide.
Business identity
- Website
- http://www.alrise.de
- Contact email
- [email protected]
- Phone number
- 49 30 94 89 24 83
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2004-01-01
Headquarters
- Headquarters
- Brackenheim, Baden-Wurttemberg, Germany
- Postal code
- 13125
- Country code
- DE
- Continent
- Europe